Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jan-24 4:04 PM View:  | Kala Bio, Inc. (KALA) | 04-Jan-24 | Grant | 14,300 | -- | -- | 5% 276.55K to 290.85K | |
| 05-Jan-24 4:04 PM View: | Kala Bio, Inc. (KALA) | 04-Jan-24 | Sale (Planned) | 4,539 | $6.73 | $30,547.50 | (2%) 290.85K to 286.31K | |
| 23-Jun-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 22-Jun-23 | Grant | 158,873 | -- | -- | 135% 117.68K to 276.55K | |
| 02-Jun-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 31-May-23 | Grant | 71,715 | -- | -- | 156% 45.97K to 117.68K | |
| 17-Apr-23 8:26 AM View: | Merus N.V. (MRUS) | 14-Apr-23 | Option Exercise | 73,576 | $7.27 | $534,679.00 | 100% 0 to 73.58K | |
| 06-Jan-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 04-Jan-23 | Grant | 41,700 | -- | -- | 934% 4.46K to 46.16K | |
| 06-Jan-23 8:00 PM View: | Kala Bio, Inc. (KALA) | 04-Jan-23 | Sale (Planned) | 198 | $28.54 | $5,650.92 | (< 1%) 46.16K to 45.97K | |
| 28-Oct-22 4:15 PM View: | Kala Bio, Inc. (KALA) | 26-Oct-22 | Private Sale (Planned) | 561 | $6.52 | $3,657.72 | (11%) 5.03K to 4.46K | |
| 29-Jun-22 8:09 PM View: | Kala Bio, Inc. (KALA) | 27-Jun-22 | Sale (Planned) | 7,975 | $0.37 | $2,950.75 | (3%) 259.16K to 251.18K | |
| 05-Jan-22 8:00 PM View: | Kala Bio, Inc. (KALA) | 04-Jan-22 | Market Sale (Planned) | 9,518 | $1.30 | $12,373.40 | (4%) 268.68K to 259.16K | 2% |
| 28-Oct-21 8:01 PM View: | Kala Bio, Inc. (KALA) | 26-Oct-21 | Market Sale (Planned) | 27,598 | $1.80 | $49,676.40 | (9%) 296.27K to 268.68K | 3% |
| 29-Jun-21 5:25 PM View: | Kala Bio, Inc. (KALA) | 28-Jun-21 | Market Sale (Planned) | 7,586 | $5.77 | $43,771.20 | (2%) 303.86K to 296.27K | 4% |
| 05-Jan-21 4:50 PM View: | Kala Bio, Inc. (KALA) | 04-Jan-21 | Grant | 76,000 | -- | -- | 33% 227.86K to 303.86K | |
| 28-Oct-20 8:24 PM View: | Kala Bio, Inc. (KALA) | 26-Oct-20 | Grant | 178,300 | -- | -- | 360% 49.56K to 227.86K | |
| 14-Oct-20 4:15 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 7,840 | $34.50 | $270,480.00 | (100%) 7.84K to 0 | |
| 14-Oct-20 4:15 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 39,567 | $34.50 | $1,365,060.00 | (100%) 39.57K to 0 | |
| 30-Jun-20 10:00 PM View: | Kala Bio, Inc. (KALA) | 25-Jun-20 | Grant | 49,560 | -- | -- | 100% 0 to 49.56K | |
| 29-May-20 7:17 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 27-May-20 | Grant | 7,840 | -- | -- | 20% 39.57K to 47.41K | |
| 28-May-19 9:17 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 23-May-19 | Grant | 6,442 | -- | -- | 19% 33.13K to 39.57K | |
| 24-May-18 5:06 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 23-May-18 | Grant | 3,750 | -- | -- | 13% 29.38K to 33.13K | |
| 05-Apr-18 8:07 PM View: | Pulmatrix, Inc. (PULM) | 03-Apr-18 | Purchase | 307,000 | -- | -- | 100% 0 to 307.0K | |
| 26-Feb-18 4:05 PM View: | Aimmune Therapeutics, Inc. (AIMT) | 26-Feb-18 | Market Purchase | 9,375 | $32.00 | $300,000.00 | 47% 20.0K to 29.38K | (24%) |
| 11-Aug-15 11:40 AM View: | Aimmune Therapeutics, Inc. (AIMT) | 11-Aug-15 | Purchase | 20,000 | $16.00 | $320,000.00 | 100% 0 to 20.0K | |
| 22-Oct-09 5:12 PM View: | Sepracor, Inc. (SEPR) | 20-Oct-09 | Disposition | 122,334 | $23.00 | $2,813,680.00 | (100%) 122.33K to 0 | < 1% |
| 19-Oct-09 5:21 PM View: | Sepracor, Inc. (SEPR) | 15-Oct-09 | Disposition (change in control) | 27,666 | $23.00 | $636,318.00 | (18%) 150.0K to 122.33K | < 1% |
| 14-May-09 9:45 PM View: | Sepracor, Inc. (SEPR) | 14-May-09 | Grant | 35,000 | $14.40 | $504,000.00 | 30% 115.0K to 150.0K | < 1% |
| 22-May-08 5:30 PM View: | Sepracor, Inc. (SEPR) | 20-May-08 | Grant | 35,000 | $21.26 | $744,100.00 | 44% 80.0K to 115.0K | (31%) |
| 22-Oct-07 4:49 PM View: | Sepracor, Inc. (SEPR) | 18-Oct-07 | Grant | 80,000 | $24.89 | $1,991,200.00 | 100% 0 to 80.0K | (41%) |